Turmeric and Gingivitis - a phase IV clinical study of FDA data

Summary:

Gingivitis is reported as a side effect among people who take Turmeric (turmeric), especially for people who are female, 60+ old, also take Epinephrine, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Gingivitis when taking Turmeric. It is created by eHealthMe based on reports of 15,564 people who have side effects when taking Turmeric from the FDA, and is updated regularly.

What is Turmeric?

Turmeric has active ingredients of turmeric. It is often used in inflammation. eHealthMe is studying from 16,563 Turmeric users. Check the latest studies of Turmeric.

What is Gingivitis?

Gingivitis (inflammation of gums) is found to be associated with 884 drugs and 803 conditions by eHealthMe. Check the latest studies of Gingivitis.

On Jul, 26, 2026

15,564 people reported to have side effects when taking Turmeric.
Among them, 16 people (0.1%) have Gingivitis.

Among these 16 people:

What is the gender of people who have Gingivitis when taking Turmeric? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Gingivitis when taking Turmeric? *

What are other drugs people take besides Turmeric? *

What are other side effects people have besides Gingivitis? *

Itching: 7 people, 43.75%
Neck Pain: 7 people, 43.75%
Oral Infection: 7 people, 43.75%
Fatigue (feeling of tiredness): 7 people, 43.75%
Fall: 5 people, 31.25%
Urinary Tract Infection: 5 people, 31.25%
Fever: 5 people, 31.25%
Dizziness: 5 people, 31.25%
Infusion Site Pruritus (severe itching at infusion site): 4 people, 25.00%
Infusion Site Erythema (reddening of the skin at infusion site): 4 people, 25.00%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 6 people, 37.50%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 31.25%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 3 people, 18.75%
Heart Disease: 3 people, 18.75%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 12.50%
Bipolar Disorder (mood disorder): 2 people, 12.50%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Turmeric and have Gingivitis?

- Check whether Gingivitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Turmeric:

Turmeric (16,563 reports)

Gingivitis treatments and more:

Gingivitis (9,610 reports)

Browse all side effects of Turmeric:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gingivitis:

Gingivitis (884 drugs)

Browse all the conditions that are associated with Gingivitis:

Gingivitis (803 conditions)

Related publications that referenced our studies

Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on turmeric (the active ingredients of Turmeric) and Turmeric (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.